CNBC: Senators reach $10 billion Covid funding deal for therapeutics, vaccines and testing
The United States Senate approved a $10 billion COVID-19 funding deal. The plan is mainly focused on funding the purchase of treatments and vaccines as well as maintaining nationwide testing. Half of the $10 billion is going towards the purchase and development of antiviral pills and $750 million in funding the development of a vaccine that will target specific variants. The deal is $12.5 billion less than what the Biden administration first requested and does not include funding to increase vaccinations worldwide as previous COVID-19 deals did. The full article by Spencer Kimball can be read here on CNBC. For more on COVID-19 click here.